Qualitative and quantitative effects of aggressive lipid-lowering therapy on atherosclerosis: Evaluation of vulnerable plaque by 64-slice MD-CT
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 01 Jul 2009
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Atherosclerosis; Hypercholesterolaemia
- Focus Therapeutic Use
- 01 Jul 2009 Additional lead trial investigator identified as reported by University Hospital Medical Information Network - Japan record.
- 29 Dec 2008 New trial record.